Acid Suppressant Therapy: a Step Forward with Potassium-Competitive Acid Blockers
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-309X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Acid Suppressant Therapy: a Step Forward with Potassium-Competitive Acid Blockers ; volume:19 ; number:1 ; day:25 ; month:1 ; year:2021 ; pages:94-132 ; date:3.2021
Current treatment options in gastroenterology ; 19, Heft 1 (25.1.2021), 94-132, 3.2021
- Urheber
-
Scarpignato, Carmelo
Hunt, Richard H.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11938-020-00330-x
- URN
-
urn:nbn:de:101:1-2021050418561571682580
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Scarpignato, Carmelo
- Hunt, Richard H.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments
Hypercontractile esophagus responsive to potassium-competitive acid blockers: a case report
Proton pump inhibitors and potassium competitive acid blockers decrease pembrolizumab efficacy in patients with metastatic urothelial carcinoma
Effect of tegoprazan, a novel potassium-competitive acid blocker, on non-steroidal anti-inflammatory drug (NSAID)-induced enteropathy
Prediction of effectiveness of potassium-competitive acid blocker and serotonin noradrenaline reuptake inhibitor on abnormal sensation in the throat: use of patient-reported outcome measures (PROMs)
Pulmonary vasoconstrictor action of KCNQ potassium channel blockers
Synthesis of Lewis Acid‐Base Adducts Between Potassium Dihydrogenpnictogenides and Group 13 Lewis Acids
Widespread use of proton pump inhibitors or potassium-competitive acid blocker has changed the status of gastrointestinal bleeding in patients with ischemic heart disease: real-world data from high volume centers
Saliva for assessing creatinine, uric acid, and potassium in nephropathic patients
Oxidative Fluorination of Heteroatoms Enabled by Trichloroisocyanuric Acid and Potassium Fluoride
Oxidative Fluorination of Heteroatoms Enabled by Trichloroisocyanuric Acid and Potassium Fluoride
Potassium Channel Blockers Tetraethylammonium and 4-Aminopyridine Fail to Prevent Microglial Activation Induced by Elevated Potassium Concentration
Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments
Hypercontractile esophagus responsive to potassium-competitive acid blockers: a case report
Proton pump inhibitors and potassium competitive acid blockers decrease pembrolizumab efficacy in patients with metastatic urothelial carcinoma
Effect of tegoprazan, a novel potassium-competitive acid blocker, on non-steroidal anti-inflammatory drug (NSAID)-induced enteropathy
Prediction of effectiveness of potassium-competitive acid blocker and serotonin noradrenaline reuptake inhibitor on abnormal sensation in the throat: use of patient-reported outcome measures (PROMs)
Pulmonary vasoconstrictor action of KCNQ potassium channel blockers
Synthesis of Lewis Acid‐Base Adducts Between Potassium Dihydrogenpnictogenides and Group 13 Lewis Acids
Widespread use of proton pump inhibitors or potassium-competitive acid blocker has changed the status of gastrointestinal bleeding in patients with ischemic heart disease: real-world data from high volume centers
Saliva for assessing creatinine, uric acid, and potassium in nephropathic patients
Oxidative Fluorination of Heteroatoms Enabled by Trichloroisocyanuric Acid and Potassium Fluoride
Oxidative Fluorination of Heteroatoms Enabled by Trichloroisocyanuric Acid and Potassium Fluoride
Potassium Channel Blockers Tetraethylammonium and 4-Aminopyridine Fail to Prevent Microglial Activation Induced by Elevated Potassium Concentration
Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments
Hypercontractile esophagus responsive to potassium-competitive acid blockers: a case report
Proton pump inhibitors and potassium competitive acid blockers decrease pembrolizumab efficacy in patients with metastatic urothelial carcinoma
Effect of tegoprazan, a novel potassium-competitive acid blocker, on non-steroidal anti-inflammatory drug (NSAID)-induced enteropathy
Prediction of effectiveness of potassium-competitive acid blocker and serotonin noradrenaline reuptake inhibitor on abnormal sensation in the throat: use of patient-reported outcome measures (PROMs)
Pulmonary vasoconstrictor action of KCNQ potassium channel blockers
Synthesis of Lewis Acid‐Base Adducts Between Potassium Dihydrogenpnictogenides and Group 13 Lewis Acids
Widespread use of proton pump inhibitors or potassium-competitive acid blocker has changed the status of gastrointestinal bleeding in patients with ischemic heart disease: real-world data from high volume centers
Saliva for assessing creatinine, uric acid, and potassium in nephropathic patients
Oxidative Fluorination of Heteroatoms Enabled by Trichloroisocyanuric Acid and Potassium Fluoride
Oxidative Fluorination of Heteroatoms Enabled by Trichloroisocyanuric Acid and Potassium Fluoride